Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis

Mol Carcinog. 1997 Sep;20(1):10-8. doi: 10.1002/(sici)1098-2744(199709)20:1<10::aid-mc3>;2-m.


The monoclonal antibody PA2.26, produced against mouse epidermal keratinocytes transformed with 7,12-dimethylbenz[a]anthracene (DMBA), recognizes a 43- to 47-kDa cell-surface protein that was absent from non-tumorigenic epidermal keratinocytes but present in transformed epidermal cell lines as well as cultured normal fibroblasts. In vivo, the antigen was absent from normal epidermis but induced in basal-like epidermal keratinocytes and dermal fibroblasts during tissue regeneration after wounding and treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). The PA2.26 protein was also expressed in basal-like cells of differentiated papillomas and carcinomas generated in mice treated with DMBA and TPA. In addition, the antigen was abundantly synthesized by stromal cells of the tumors. These results suggest that PA2.26 antigen is involved in reactive processes during skin remodeling and carcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Antibodies, Monoclonal
  • Antigens, Neoplasm / biosynthesis*
  • Antigens, Surface / biosynthesis*
  • Carcinogens
  • Cell Transformation, Neoplastic
  • Cells, Cultured
  • Fibroblasts / metabolism*
  • Keratinocytes / metabolism*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Microscopy, Fluorescence
  • Skin / cytology
  • Skin / drug effects
  • Skin / metabolism*
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / metabolism*
  • Stromal Cells / cytology
  • Stromal Cells / drug effects
  • Stromal Cells / metabolism


  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Antigens, Surface
  • Carcinogens
  • 9,10-Dimethyl-1,2-benzanthracene